Patent: 10,046,081
✉ Email this page to a colleague
Summary for Patent: 10,046,081
Title: | Electrospun dextran fibers and devices formed therefrom |
Abstract: | The invention generally relates to dextran fibers which are preferably electrospun and devices formed from such fibers. In particular, such devices may include substances of interest (such as therapeutic substances) associated with the electrospun fibers. Upon exposure to a liquid the electrospun fibers dissolve immediately and the substances of interest are released into the liquid. Exemplary devices include bandages formed from electrospun dextran fibers and associated agents that promote hemostasis, such as thrombin and fibrinogen. |
Inventor(s): | Bowlin; Gary (Mechanicsville, VA), Simpson; David (Mechanicsville, VA), Bowman; James (Richmond, VA), Rothwell; Stephen (Richmond, VA) |
Assignee: | The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. (Rockville, MD) Virginia Commonwealth University (Richmond, VA) |
Application Number: | 14/445,566 |
Patent Claims: | see list of patent claims |
Details for Patent 10,046,081
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | Solution | 125247 | 08/27/2007 | ⤷ Try a Trial | 2028-04-11 |
Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | For Injection | 125247 | 09/17/2009 | ⤷ Try a Trial | 2028-04-11 |
Csl Behring Gmbh | RIASTAP | fibrinogen concentrate (human) | For Injection | 125317 | 01/16/2009 | ⤷ Try a Trial | 2028-04-11 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | FIBRYGA, FIBRYNA | fibrinogen (human) | For Injection | 125612 | 06/07/2017 | ⤷ Try a Trial | 2028-04-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |